Compartir
Información de la revista
Número
Vol. 24. Núm. 4.Páginas 261-406 (octubre - diciembre 2023)
Editorial
Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar?
Fernando Moraga-Llop, Magda Campins-Martí
Vacunas. 2023;24:261-5
Originales
Effects of sub-inhibitory concentration of antibiotic and heat stress on the expression of type II TA system genes in Brucella spp.
Fatemeh Amraei, Negar Narimisa, Shiva Mirkalantari, Shabnam Razavi, Behrooz Sadeghi Kalani, Faramarz Masjedian Jazi
Vacunas. 2023;24:266-72
The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study
Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
Vacunas. 2023;24:273-7
Impact of vaccination on the entire population and dose-response relation of COVID-19
Abdul Malek, Ashabul Hoque
Vacunas. 2023;24:278-90
Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study
Narayana Goruntla, Basappa Karisetty, Nandini Nandini, Bharadwaj Bhupasamudram, Himaja Reddy Gangireddy, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru
Vacunas. 2023;24:291-7
The feasibility of including human papillomavirus vaccine in Iran's national immunization program
Maryam Honarvar, Reza Goudarzi, Mohammadreza Amiresmaili, Asrin Amiri, Abdul Sami Saeed Paul
Vacunas. 2023;24:298-307
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria
Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
Vacunas. 2023;24:308-16
Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model
Anmar Al-Taie, Zekiye Yilmaz
Vacunas. 2023;24:317-25
COVID vaccine: Social, menstrual and psychological aftermath
Swati Gupta, Divya Rai, Shipra Shukla
Vacunas. 2023;24:326-34
Impacto de la vacunación en la mortalidad de adultos colombianos con síndrome de dificultad respiratoria aguda por SARS-CoV-2 que requirieron ventilación mecánica invasiva
Yina Daniela Benítez Patiño, Luis Carlos Triana, Oscar Mauricio Muñoz Velandia, Viviana Yiset López Ramírez, Laura María Niño Guerra, Santiago Bottia Córdoba
Vacunas. 2023;24:335-40
COVID-19 immune response in adults post Measles-Rubella vaccination
Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
Vacunas. 2023;24:341-7
Revisiones
ERX-41; Promising compound by targeting LIPA is a new Achilles heel therapeutic strategy for hard-to-treat solid tumors by induction of endoplasmic reticulum stress
Majid Eslami, Mohammad Memarian, Bahman Yousefi
Vacunas. 2023;24:348-57
CHECKvacc (HOV3, CF33-hNIS-anti-PD-L1), the next medical revolution against cancer
Ali Adel Dawood
Vacunas. 2023;24:358-63
The global spread of human monkeypox virus: Challenges and opportunities for prevention
Muhammad Safdar, Shafeeq Ur Rehman, Furqan Shafqat, Muhammad Shan, Samiha S. Khan, Faiz-ul Hassan, Hafiz Khawar Ali, Mehmet Ozaslan
Vacunas. 2023;24:364-79
Desarrollo de vacunas
Immuno-informatics design of a multimeric epitope peptide-based vaccine against dengue virus serotype-2
Mohamed Sheik Tharik Abdul Azeeze, Rajaguru Arivuselvam
Vacunas. 2023;24:380-93
Estrategia vacunal
Quince años de vacunación frente al virus del papiloma humano en España. Actualización
F. Moraga-Llop
Vacunas. 2023;24:394-9
Cartas al director
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspective
Farhad Dadgar, Jorge Casseb, Masoud Keikha
Vacunas. 2023;24:400-1
The impact of vaccination against monkeypox on risk of mpox reinfection
Farhad Dadgar, Jalil Rouhani, Fatemeh Dehghani, Masoud Keikha
Vacunas. 2023;24:402-3
To assess mortality from COVID-19 in patients with comorbidities, it is crucial to perform an autopsy
Josef Finsterer
Vacunas. 2023;24:404-5
Fe de errores